MANE Hedge Fund Ownership (Q2 2026)

Q: Is it too late to buy Veradermics Inc Common Stock (MANE) following the 2026 Q3 hedge fund 13F filings?

As of today, MANE has moved +0.0% since the 2026 Q3 13F filing date (November 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (September 30, 2026), MANE gained +7.0% vs +12.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Veradermics Inc Common Stock (MANE)

161 + Investors. Track Smart Money conviction in MANE. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — MANE

Based on 161 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 1Q

For 1 consecutive quarter, more hedge funds added MANE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

161 hedge funds hold MANE right now — the highest count in 0.5 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🟢

More buyers than sellers — 81% buying

136 buying32 selling

Last quarter: 136 funds were net buyers (96 opened a brand new position + 40 added to an existing one). Only 32 were sellers (19 trimmed + 13 sold completely). A clear majority buying is a strong confirmation signal.

🔄

Mostly new holders — 100% entered in last year

■ 0% conviction (2yr+) ■ 0% medium ■ 100% new

Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💰

Value +166% but shares only +48% — price-driven

Value

+165%

+48%

Last quarter: the total dollar value of institutional holdings rose +166%, but actual share count only changed +48%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

🌱

Early stage — 100% of holders entered in last year

■ 0% veterans ■ 0% 1-2yr ■ 100% new

Of 161 current holders: 161 (100%) entered in the past year, only 0 (0%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

✅

Strong quality — 39% AUM from major funds

39% from top-100 AUM funds

40 of 161 holders rank in the top 100 by AUM, accounting for 39% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

5.5

out of 10

Moderate Exit Risk

Exit risk score 5.5/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	161	78	106.41%
13F Shares	37M	25M	48.46%
Total Value	$4.19B	$1.57B	165.94%
New Positions	96	78	+18
Increased Positions	40	0	+40
Closed Positions	13	0	+13
Reduced Positions	19	0	+19
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

161

106.41%

13F Shares

37M

25M

48.46%

Total Value

$4.19B

$1.57B

165.94%

New Positions

+18

Increased Positions

+40

Closed Positions

+13

Reduced Positions

+19

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q3)

161 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in MANE. Verified SEC 13F-HR filings.

QUARTER:

2026 Q3 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 MANE holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Kalehua Capital Management LLC	13.34%	145,695	$17.7M
2	Siren, L.L.C.	3.79%	1,324,299	$160.5M
3	HighVista Strategies LLC	1.73%	54,232	$6.6M
4	Emerald Mutual Fund Advisers Trust	1.11%	225,552	$27.3M
5	Emerald Advisers, LLC	1.11%	332,395	$40.3M
6	Blue Owl Capital Holdings LP	1.00%	45,000	$5.5M
7	MYDA Advisors LLC	0.88%	65,000	$7.9M
8	Atika Capital Management LLC	0.69%	70,500	$8.5M
9	Formula Growth Ltd	0.64%	13,798	$1.7M
10	Affinity Asset Advisors, LLC	0.39%	79,400	$9.6M
11	Atle Fund Management AB	0.33%	10,106	$1.2M
12	F/m Investments LLC	0.13%	37,030	$4.5M
13	Black Swift Group, LLC	0.13%	7,500	$909K
14	WINTON GROUP Ltd	0.13%	26,950	$3.3M
15	Capricorn Fund Managers Ltd	0.12%	10,824	$1.3M
16	Virtus Investment Advisers, LLC	0.09%	3,303	$400K
17	Legato Capital Management LLC	0.09%	8,085	$980K
18	Private Capital Advisors, Inc.	0.07%	6,291	$763K
19	Ensign Peak Advisors, Inc	0.06%	275,770	$33.4M
20	Profund Advisors LLC	0.06%	15,843	$1.9M
21	Persistent Asset Partners Ltd	0.05%	1,576	$191K
22	Axq Capital, LP	0.05%	3,011	$365K
23	Quantbot Technologies LP	0.04%	9,473	$1.1M
24	Wilshire Advisors LLC	0.04%	134,156	$16.3M
25	Alps Advisors Inc	0.03%	55,356	$6.7M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Veradermics Inc Common Stock (MANE)

What does the Smart Money Trend signal show for MANE?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added MANE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for MANE?

More buyers than sellers — 81% buying: Last quarter: 136 funds were net buyers (96 opened a brand new position + 40 added to an existing one). Only 32 were sellers (19 trimmed + 13 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for MANE holders?

Strong quality — 39% AUM from major funds: 40 of 161 holders rank in the top 100 by AUM, accounting for 39% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held MANE?

Mostly new holders — 100% entered in last year: Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Veradermics Inc Common Stock (MANE) following the 2026 Q3 hedge fund 13F filings?

As of today, MANE has moved +0.0% since the 2026 Q3 13F filing date (November 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (September 30, 2026), MANE has gained +7.0% vs +12.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Veradermics Inc Common Stock (MANE)

Smart Money Signals — MANE

Buying streak — 1 quarter in a row

At the ownership peak (100% of max)

More buyers than sellers — 81% buying

Mostly new holders — 100% entered in last year

Value +166% but shares only +48% — price-driven

Early stage — 100% of holders entered in last year

Strong quality — 39% AUM from major funds

Institutional Sentiment Summary — MANE

Hedge Fund Ownership: MANE

Market Analysis: MANE

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: MANE

Is It Too Late to Buy Veradermics Inc Common Stock (MANE) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: MANE

Statistics: MANE

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q3)

Frequently Asked Questions — Veradermics Inc Common Stock (MANE)

Welcome to 13Foresight!